Back to top

Buy Recommendation for Gilead Sciences Amid Strategic Positioning and Legal Developments

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Gilead Sciences and keeping the price target at $143.00. Terence Flynn has giv...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)